CV-IC-07 · standards
FDCA s.201(m), 21 U.S.C. 321(m)
“'labeling' includes matter accompanying the article, which FDA has applied to brand websites and other owned content”
FDCA s.201(g)(1)(B), 21 U.S.C. 321(g)(1)(B)
“definition of 'drug': articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease”
Source checked 2026-08-18.
FTC Act s.5(a), 15 U.S.C. 45(a)
“unfair or deceptive acts or practices in or affecting commerce”
Source checked 2026-08-18.
An interpretation. We applied a published legal test to the published copy and reached a conclusion. Reasonable reviewers applying the same test can disagree at the margin; this is our reviewer's professional opinion, and the test is cited so you can check the reasoning.
Claims Verified, standard CV-IC-07 "Disease claim in email flows", standards v1.3.1, retrieved 16 September 2026, https://claimsverified.org/standards/CV-IC-07/
Or put it in your own policy
Marketing copy must not use "Disease claim in email flows" or equivalent wording. See Claims Verified standard CV-IC-07 (standards v1.3.1): https://claimsverified.org/standards/CV-IC-07/
Cite it freely with attribution and the version. The whole register is machine-readable at /standards/registry.json. Rulings are our published professional opinion, not legal advice.
All 98 standards and the 98 in force · Check a listing against them free